BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30706549)

  • 1. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention.
    Solman L; Lloyd-Lavery A; Grindlay DJC; Rogers NK; Thomas KS; Harman KE
    Clin Exp Dermatol; 2019 Jun; 44(4):363-369. PubMed ID: 30706549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies.
    Olabi B; Worboys S; Garland T; Grindlay DJC; Rogers NK; Harman KE
    Clin Exp Dermatol; 2020 Dec; 45(8):980-985. PubMed ID: 32568435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies.
    Tasker F; Brown A; Grindlay DJC; Rogers NK; Harman KE
    Clin Exp Dermatol; 2020 Dec; 45(8):974-979. PubMed ID: 32852805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 2. Treatment and prevention.
    Lloyd-Lavery A; Rogers NK; Hatfield SJ; Grindlay D; Barnett R; Thomas KS
    Clin Exp Dermatol; 2017 Jan; 42(1):3-7. PubMed ID: 27868221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in atopic eczema? An analysis of systematic reviews published in 2010-11.
    Torley D; Futamura M; Williams HC; Thomas KS
    Clin Exp Dermatol; 2013 Jul; 38(5):449-56. PubMed ID: 23750610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 2: prevention and treatment.
    Lloyd-Lavery A; Rogers NK; Davies E; Grindlay DJC; Thomas KS
    Clin Exp Dermatol; 2018 Aug; 43(6):653-658. PubMed ID: 29806218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
    Schmitt J; von Kobyletzki L; Svensson A; Apfelbacher C
    Br J Dermatol; 2011 Feb; 164(2):415-28. PubMed ID: 20819086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's new in atopic eczema? An analysis of the clinical significance of systematic reviews on atopic eczema published in 2006 and 2007.
    Williams HC; Grindlay DJ
    Clin Exp Dermatol; 2008 Nov; 33(6):685-8. PubMed ID: 18691244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What's new in atopic eczema? An analysis of systematic reviews published in 2019. Part 2: treatment.
    Marrouche N; Lancaster N; Grindlay DJC; Rogers NK; Olabi B
    Clin Exp Dermatol; 2021 Oct; 46(7):1211-1215. PubMed ID: 34080205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Treatment of Atopic Dermatitis.
    Prezzano JC; Beck LA
    Dermatol Clin; 2017 Jul; 35(3):335-349. PubMed ID: 28577803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 1: treatment and prevention.
    Wernham AGH; Veitch D; Grindlay DJC; Rogers NK; Harman KE
    Clin Exp Dermatol; 2019 Dec; 44(8):861-867. PubMed ID: 31392785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.
    Nankervis H; Thomas KS; Delamere FM; Barbarot S; Smith S; Rogers NK; Williams HC
    Br J Dermatol; 2017 Apr; 176(4):910-927. PubMed ID: 27547965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of treatment escalation as a definition of atopic eczema flares.
    Thomas KS; Stuart B; O'Leary CJ; Schmitt J; Paul C; Williams HC; Langan S
    PLoS One; 2015; 10(4):e0124770. PubMed ID: 25897763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new in the topical treatment of allergic skin diseases.
    Aslam I; Sandoval LF; Feldman SR
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):436-50. PubMed ID: 25061854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not Available].
    Darrigade AS
    Ann Dermatol Venereol; 2019 Dec; 146(12S3):12S85-12S95. PubMed ID: 31997737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in atopic eczema? An analysis of systematic reviews published in 2007 and 2008. Part 2. Disease prevention and treatment.
    Williams HC; Grindlay DJ
    Clin Exp Dermatol; 2010 Apr; 35(3):223-7. PubMed ID: 19874342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Eczema: Corticosteroids and Beyond.
    Chong M; Fonacier L
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):249-262. PubMed ID: 25869743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's new in atopic eczema? An analysis of systematic reviews published in 2012 and 2013. Part 2. Treatment and prevention.
    Madhok V; Futamura M; Thomas KS; Barbarot S
    Clin Exp Dermatol; 2015 Jun; 40(4):349-54; quiz 354-5. PubMed ID: 25622761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
    Green C; Colquitt JL; Kirby J; Davidson P; Payne E
    Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
    Wilkes SR; Nankervis H; Tavernier E; Maruani A; Williams HC
    J Invest Dermatol; 2016 Oct; 136(10):1944-1949. PubMed ID: 27265005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.